Controlled discontinuation of benzodiazepine treatment for patients with panic disorder
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The purpose of this study was to compare the effects of discontinuing treatment with intermediate- and long-acting benzodiazepines. METHOD: Fifty patients with panic disorder who had taken part in a double-blind treatment study and had responded to alprazolam, diazepam, or placebo for 8 months were asked to stop taking these medications gradually. RESULTS: After a relatively rapid dose reduction, the majority of patients relapsed. Rebound anxiety and withdrawal symptoms were identified in a substantial minority of patients. Those who were taking alprazolam showed earlier and more intense rebound anxiety and withdrawal symptoms than did the patients who received diazepam. Both the level of pretreatment anxiety and the drug the patient was taking predicted the level of anxiety when drug treatment was discontinued. CONCLUSIONS: The findings indicate that withdrawal phenomena commonly occur after patients stop taking benzodiazepines and that they are more frequent after discontinuation of treatment with shorter-acting drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Discontinuation of alprazolam treatment in panic patients
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.3.303 · Cited by 172
Cited by
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1485 · Cited by 263
Brown, T. A., & Barlow, D. H. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.5.754 · Cited by 262
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
The benzodiazepine withdrawal syndrome
PÉTURSSON, H. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03743.x · Cited by 246
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R., & Tepner, R. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.363 · Cited by 181
Schweizer, E. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130053009 · Cited by 120
Otto, M. W., McHugh, R. K., Simon, N. M., Farach, F. J., Worthington, J. J., & Pollack, M. H. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.002 · Cited by 95
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
Bruce, T. J., Spiegel, D. A., & Hegel, M. T. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.1.151 · Cited by 69
Otto, M. W., Safren, S. A., & Pollack, M. H. (2004) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2003.07.007 · Cited by 68
Otto, M. W., Powers, M. B., & Fischmann, D. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.05.002 · Cited by 67
Evidence-based pharmacotherapy of panic disorder: an update
Batelaan, N. M., Van Balkom, A. J. L. M., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000800 · Cited by 67
“Discontinuation of pharmacotherapy frequently results in relapse (Ferguson et al. 2007; Lecrubier & Judge, 1997 ; LotufoNeto et al. 2001; Marks et al. 1993; Mavissakalian & Perel, 1999; Noyes et al. 1989, 1991 ; Rapaport et al. 2001; Spiegel et al. 1994).”
BackgroundA pilot open trial of brief psychodynamic psychotherapy for panic disorder.
(2001) · PubMed Central · Cited by 66
The dependence potential of short half-life benzodiazepines: a meta-analysis
Hallfors, D. D., & Saxe, L. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.9.1300 · Cited by 54
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1760 · Cited by 44
Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822d0012 · Cited by 34
Review: Adjunctive pharmacologic approaches for benzodiazepine tapers
Welsh, J. W., Tretyak, V., McHugh, R. K., Weiss, R. D., & Bogunovic, O. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.028 · Cited by 31
Attending to Emotional Cues for Drug Abuse: Bridging the Gap Between Clinic and Home Behaviors
Otto, M., O'Cleirigh, C., & Pollack, M. (2007) · Science & Practice Perspectives · doi:10.1151/spp073248 · Cited by 26
“Many patients fail to complete BZ tapers because they cannot tolerate the anxiety and panic that occur and reportedly rival or exceed in intensity the sensations that motivated the use of the medications in the first place (Fyer et al., 1987; Mellman and Uhde, 1986; Noyes et al., 1991).”
Long-term drug treatment of panic disorder
Burrows, G. D., Judd, F. K., & Norman, T. R. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90022-t · Cited by 19
O'Sullivan, G. H., Swinson, R., Kuch, K., Marks, I. M., Basoglu, M., & Noshirvani, H. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000204 · Cited by 10
A Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Kauffman, B. Y., Diamond, A., & Smits, J. A. J. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00026-1 · Cited by 3
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1991-04-01
- Volume
- 148
- Issue
- 4
- Pages
- 517-523
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W164852580
- Cited by
- 111
- References
- 3
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.